Events & Presentations

Upcoming Events

Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.

Archived Events
Date Details
May 9, 2017
8:30 AM ET
Chimerix Q1 2017 Earnings Conference Call
Apr 27, 2017
4:30 PM ET
Chimerix Annual Investor Update
Mar 7, 2017
8:00 AM ET
Cowen and Company 37th Annual Health Care Conference
Speaker: Garrett Nichols, M.D., M.S., Chief Medical Officer
Mar 2, 2017
8:30 AM ET
Chimerix Q4 2016 Earnings Conference Call
Feb 23, 2017
Treatment of Adenovirus (ADV) Infection In Allogeneic Hematopoietic Cell Transplant Patients With Brincidofovir: Final 36 Week Results From The Advise Trial
Jan 11, 2017
8:30 AM PT
J.P. Morgan 35th Annual Healthcare Conference
Speaker: M. Michelle Berrey, M.D., M.P.H, President and Chief Executive Officer
Location: The Westin Saint Francis Hotel in San Francisco, CA
Nov 15, 2016
1:30 PM ET
Stifel 2016 Healthcare Conference
Location: Lotte New York Palace Hotel in New York
Nov 7, 2016
8:30 AM ET
Chimerix Q3 2016 Earnings Conference Call
Sep 12, 2016
4:15 PM ET
Morgan Stanley Global Healthcare Conference
Speaker: M. Michelle Berrey, M.D., M.P.H, Chief Executive Officer
Location: Grand Hyatt Hotel in New York City.
Aug 8, 2016
8:30 AM ET
Chimerix Q2 2016 Earnings Conference Call
Feb 22, 2016
8:00 AM ET
Corporate Update Call on SUPPRESS Results and Brincidofovir Program
Feb 20, 2016
9:00 PM ET
Presentation of Phase 3 SUPPRESS Detailed Results at BMT Tandem Meetings
Dec 28, 2015
8:30 AM ET
Chimerix Corporate Update
Feb 12, 2015
BMT Tandem Meeting
Abstract Preliminary Results from the AdVise Study Evaluating Brincidofovir (BCV, CMX001) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Feb 12, 2015
BMT Tandem Meeting
Presentation Preliminary Results from the AdVise Study Evaluating Brincidofovir (BCV, CMX001) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection
Speaker: Michael Grimley, MD
Presentations
Date Title
Apr 27, 2017
Feb 18, 2016
= add file to Briefcase